Toxicology Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Question | Answer |
| study of adverse effects of chemicals in living organisms | toxicology |
| agent that can cause a deleterious response in a biological system | poison |
| toxic substances produced by biological systems | toxin |
| toxic substances produced by or are by-products of anthropogenic activities (man's activity) (exogenous) | toxicant |
| compound found in an organism but not normally produced by or expected to be present in that organism | xenobiotic |
| three approaches to toxicology (subject areas) | mechanistic, descriptive, regulatory |
| specialties (practice areas in toxicology) | food, analytical/forensic, clinical, occupational, regulatory, environmental |
| specialized areas of application: | risk assessment and toxicogenomics |
| Field that identifies and understands cellular, biochemical, and molecular mechanisms causing toxic effects (work in labs ; work at the bench) | Mechanistic |
| data from these studies are used in risk assessment, design and production of safer alternative chemicals, therapy for poisonings, treatment of disease; contributes to knowledge of basic physiology pharmacology, cell biology and biochem (basic science) | Mechanistic |
| Field that describes gross toxic responses using in vitro and in vivo systems | descriptive toxicology |
| data from these studies used for safety eval. for human health and environmental risk assessments, provides a starting point for elucidating mechanisms | Descriptive |
| science of determining if drugs and chemicals are safe for use... use information from descriptive and mechanistic toxicity data and epidemiology data (PAPER scientist) | Regulatory toxicology |
| process to evaluate the potential for adverse health or environmental effects from exposure to naturally occuring or synthetic agents; includes estimate of probability of harm and description of assumptions and uncertainties that go into it | Risk Assessment |
| its goal is to provide risk managers with a rational basis for making decisions about managing the use of chemicals or physical gents to protect health and the environment | Risk Assessment |
| emerging sub-discipline of toxicology ; contibute to DNA; data from these techniques are descriptive but also provide info on mechanisms | Toxicogenomics |
| hybrid of analytical chemistry and toxicological principles | forensics toxicology |
| area of medicine concerned with disease caused by or uniquely associated with toxic substances | clinical toxicology |
| applies the principles and methodology of toxicology to chemical and biological hazards in the workplace | occupational toxicology |
| they work to set levels for safe exposures to: environmental contaminants, food additives, medicinals | Regulatory toxicology |
| concerned with impacts of pollutants on nonhuman organisms and human health | environmental technology |
| specialized areas of environmental toxicology; focuses on impacts of toxic substances on population dynamics in ecosystem | ecotoxicology |
| three things importnant in environmental toxicology | transport, fate, and interactions |
| when was the american association of poison control centers formed | 1958 |
| exam for toxicology is administered by__________ and taken to become _________ | AACT (american academy of clinical toxicology); DABAT (diplomat of american board of applied toxicology) |
| to become CSPI (certified specialist in poison info) .... | need 2000 hrs of logged calls and 2000 hrs of other... take it every 7 years |
| no toxic effect unless poison: | reaches sensitive site, site at concentration sufficient to produce effect, reaches site for length of time sufficient to prod. effect (SITE, CONCENTRATION, TIME) |
| occurrence of toxic effect is dependent on: | chemical/physical properties, exposure, metabolized, concentration, susceptibility |
| adverse effects from meds due to: | genetic predisposition, nonselective action, inappropriate use or admin |
| main reason drugs pulled from market | drug TOXICITY |
| 2 offices in charge of drug safety in FDA | office in drug safety ; drug safety oversight board |
| TOCP (triorthocresylphosphate) | inhibits neuropathy target esterase so binds irreversible (delayed effect) --> 3-5 days later you get tingling and lose ability to move |
| when combined effect is equal to sum of the two compounds given alone | additive |
| when combined effect is much greater than the sum of the effects of each given alone | synergistic |
| when one subs. does not have a toxic effect but when added to another makes second compound more toxic than it would be alone | potentiation |
| when two compounds together interfere with each other's effect | antagonism |
| decreased responsiveness to a toxic effect resulting from prior exposuure to a chemical or strucutrally related compound | tolerance |
| less of a toxic agent reaching its target | dispositional tolerance |
| receptor expression repression | reduced responsiveness |
| principles of toxicology | source, exposure, ADME, Dose, MOA, endpoint(target) |
| exposure for 1 month or less | subacute |
| exposure for 1-3 months | subchronic |
| exposure for more than 3 months | chronic |
| less than 24 hour exposure | acute |
Created by:
aisdancer